A 42-year-old man is found slumped sideways on a bus stop bench, one shoe half off, lips dusky in the morning heat. His backpack is open, a crushed foil wrapper stuck to the lining, and his respirations are slow enough that you can count them without hurrying. The monitor shows a pulse that is present but sleepy, and the room smells faintly of stale smoke and damp clothes. He does not wake when his shoulder is shaken, and the next breath feels like the one that matters.

— What’s your move? Read on.

Before you read
  • How do you recognize the long-acting or high-potency exposure that will outlast a single reversal?
  • What complications do you need to anticipate after the breathing is fixed?

When to Think of It

Opioid toxidrome: depressed mental status, respiratory depression, and miosis are classic, but miosis may be absent with hypoxia, coingestants, or potent synthetics. Think opioids with unexplained bradypnea, apnea, pinpoint pupils, cyanosis, or a patient who improves briskly with naloxone.

Sick or Not Sick

The single fork is ventilating adequately vs not. If respirations are inadequate, give oxygen and assist ventilation immediately; naloxone is for restoring spontaneous breathing, not proving the diagnosis.

The First Fifteen Minutes

  • RR low, apnea, cyanosis, or rising CO2 → bag-valve-mask ventilation now with airway positioning and suction, because ventilation fixes the immediate lethal problem.
  • Suspected opioid toxidrome with inadequate respirations → naloxone 0.04 mg IV, repeat every 2–3 minutes escalating to 0.4 mg IV, then 2 mg IV as needed; if no IV, give 2 mg intranasal or 4 mg intranasal per device availability, because it competitively displaces opioid from the receptor and restores respiratory drive.
  • If no response after adequate dosing → consider massive fentanyl, mixed ingestion, or alternate diagnosis; continue ventilation and airway management rather than pushing endlessly, because naloxone cannot fix non-opioid coma.
  • Recurrent respiratory depression after initial response → start naloxone infusion at two-thirds of the effective wake-up dose per hour IV, because naloxone’s half-life is shorter than many opioids.
  • Severe agitation, vomiting, or withdrawal after reversal → pause further escalation and titrate smaller doses, because the goal is breathing, not full arousal.
  • If aspiration or hypoxia occurred → oxygen, suction, and prepare for intubation if ventilation remains inadequate, because post-reversal pulmonary complications can still kill.

Definitive Care & Disposition

Observe for recurrent sedation, especially after methadone, extended-release opioids, fentanyl analogs, body stuffing, or coingestants. Admit any patient needing repeated naloxone, infusion, intubation, or with aspiration, pulmonary edema, rhabdomyolysis, or hypoxic injury; ICU if airway/ventilation remains tenuous. Offer addiction treatment, naloxone kit, and overdose prevention counseling before discharge when appropriate.

How This One Kills

Assuming “snoring but breathing” is safe. Opioid hypoventilation can look like sleep until CO2 climbs, the patient tires, and apnea follows.
The Differential — What Else Looks Like This
  • Sedative/hypnotic overdose — pupils are usually not pinpoint; the cost of confusion is missing mixed ingestion or alternative coma.
  • Pontine hemorrhage — small pupils and coma can mimic opioid poisoning; the cost is failing to image a catastrophic bleed.
  • Clonidine toxicity — bradycardia and miosis may resemble opioids; the cost is missing a different toxidrome with prolonged CNS depression.
  • Hypoglycemia — altered mental status can be indistinguishable early; the cost is missing the fastest reversible cause of coma.

The Second-Day Story

In older adults, opioid toxicity may present as falls, delirium, or “failure to thrive,” with less obvious miosis and more baseline hypoxia. In tolerant patients, the danger is not the degree of sleepiness but the slow respiratory rate and shallow tidal volume; in mixed ingestions, naloxone may partially help but not fully wake the patient. Always check glucose and consider coingestants when the response is incomplete.
Back to Our Patient
Back to our 42-year-old man on the bus stop bench with dusky lips and shallow respirations. He fits opioid toxicity by the bedside pattern of coma plus hypoventilation, so the first move is bag-valve-mask ventilation while naloxone is titrated from a low IV dose to restore breathing without overshooting into violent withdrawal. If he responds but fades again, that tells you the exposure is longer acting than naloxone and he needs an infusion and monitored admission rather than a quick discharge. With recurrent respiratory depression and likely aspiration risk, he belongs in a monitored setting, and after stabilization he should leave with overdose prevention and treatment linkage.
Patient Presentation to Attending
How you’d present this patient on the floor — tight, pertinent positives and negatives, no rambling
This is a 42-year-old man found unresponsive at a bus stop with bradypnea and cyanotic lips. He has no meaningful response to verbal stimuli, and on exam his respirations are shallow with depressed mental status; pupils are small but reactive, and there’s no focal neurologic deficit. Glucose is normal, oxygen saturation is low, and I’m concerned for opioid toxicity causing hypoventilation. I’ve started bag-valve-mask ventilation and titrated naloxone to restore spontaneous respirations, and I’m watching for recurrent sedation that would require an infusion and monitored admission.

Study Directive

  • Draw the opioid toxidrome from memory: mental status, respiratory rate, pupils, bowel sounds, skin, and temperature.
  • Practice a naloxone titration script starting at 0.04 mg IV and escalating to effect; say out loud when you would stop escalating.
  • Review criteria for naloxone infusion and compute a sample infusion rate from a hypothetical wake-up dose.
  • Rehearse a 30-second oral presentation distinguishing opioid coma from sedative-hypnotic coma and pontine hemorrhage.
  • Check your institution’s naloxone device options: IV, IM, intranasal strengths, and infusion preparation.

Recent Literature